Walgreens
Prix: 11.98Entreprise et modèle économique
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Its core products include prescription medications, health and wellness products, and retail pharmacy services. Major business segments consist of Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The primary revenue sources are retail sales of pharmaceuticals and health products, along with pharmacy services.
Profil d’investissement
The investment profile of Walgreens is more aligned with value investors, given its current stock performance and market position. The company may appeal to those seeking stability rather than aggressive growth, as it faces challenges in profitability. The stock is suitable for medium to long-term horizons, with moderate liquidity.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- -7.29 Risque
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 1.0% ≈
- Surprise BPA
- 44.4% meilleur que prévu
- Volatilité 20 j
- 0.6% stable
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-09 02:55 | Conserver | Vendre | Weak fundamentals and high risk limit upside potential. |
| 2026-06-01 02:54 | Vendre | Conserver | Weak fundamentals and high risk limit upside potential. |
| 2026-05-08 15:09 | — | Vendre | Weak fundamentals and high risk limit upside potential. |
Rien pour le moment